glp 1 agonist trials Another milestone in the evolution of GLP-1-based diabetes therapies Clinical Outcomes with GLP-1 Receptor
Description
European Heart Journal
Cell Rep 17: 2845-2856, 2016
Endnotes Adults who say a doctor or health care provider told them they are overweight or obese in the past five years include those who may also have diabetes or heart disease
Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Diamant M, et al
doi: 10.1016/j.bbr.2018.08.006 [DOI] [PubMed] [Google Scholar] 128.Al Qassab M, Mneimneh M, Jradi A, et al
